Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin.

Autor: Chekhun VF; Department of Mechanisms of Anticancer Therapy, R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kiev, Ukraine., Lukyanova NY, Burlaka CA, Bezdenezhnykh NA, Shpyleva SI, Tryndyak VP, Beland FA, Pogribny IP

Publikováno v: International journal of oncology [Int J Oncol] 2013 Nov; Vol. 43 (5), pp. 1481-6. Date of Electronic Publication: 2013 Aug 20.

Chronic administration of 2-acetylaminofluorene alters the cellular iron metabolism in rat liver.

Autor: Shpyleva SI; Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079, USA., Muskhelishvili L, Tryndyak VP, Koturbash I, Tokar EJ, Waalkes MP, Beland FA, Pogribny IP

Publikováno v: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2011 Oct; Vol. 123 (2), pp. 433-40. Date of Electronic Publication: 2011 Jul 23.

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.

Autor: Pogribny IP; Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA. igor.pogribny@fda.hhs.gov, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, Kovalchuk O

Publikováno v: International journal of cancer [Int J Cancer] 2010 Oct 15; Vol. 127 (8), pp. 1785-94.

The use of nanoferromagnetics to increase the cytotoxic effect of antitumor drugs.

Autor: Chekhun VF; R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kiev, Ukraine. todor_igor@yahoo.com, Todor IN, Lukyanova NY, Shpyleva SI, Naleskina LA, Khaetsky IK, Kulik GI

Publikováno v: Experimental oncology [Exp Oncol] 2009 Sep; Vol. 31 (3), pp. 163-7.